Journey Medical Corp (DERM)
3.45
-0.17
(-4.70%)
USD |
NASDAQ |
May 17, 16:00
3.45
0.00 (0.00%)
After-Hours: 20:00
Journey Medical Revenue (Quarterly): 13.03M for March 31, 2024
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 13.03M |
| December 31, 2023 | 15.26M |
| September 30, 2023 | 34.54M |
| June 30, 2023 | 17.17M |
| March 31, 2023 | 12.21M |
| December 31, 2022 | 15.97M |
| September 30, 2022 | 16.12M |
| June 30, 2022 | 18.29M |
| Date | Value |
|---|---|
| March 31, 2022 | 23.30M |
| December 31, 2021 | 17.52M |
| September 30, 2021 | 19.61M |
| June 30, 2021 | 15.29M |
| March 31, 2021 | 10.72M |
| December 31, 2020 | 13.72M |
| September 30, 2020 | 9.447M |
| June 30, 2020 | 9.415M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
9.415M
Minimum
Jun 2020
34.54M
Maximum
Sep 2023
16.35M
Average
15.63M
Median
Revenue (Quarterly) Benchmarks
| Fortress Biotech Inc | 19.95M |
| Stereotaxis Inc | 6.88M |
| GT Biopharma Inc | -- |
| Cara Therapeutics Inc | 2.135M |
| FibroGen Inc | 55.90M |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | -10.44M |
| Total Expenses (Quarterly) | 23.12M |
| EPS Diluted (Quarterly) | -0.53 |
| Enterprise Value | 62.93M |
| Gross Profit Margin (Quarterly) | 47.69% |
| Profit Margin (Quarterly) | -80.14% |
| Earnings Yield | -8.99% |
| Operating Earnings Yield | 0.80% |
| Normalized Earnings Yield | -3.701 |